Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.83 Billion CNY | 2.76% |
| 2022 | 2.6 Billion CNY | -7.56% |
| 2021 | 2.82 Billion CNY | 1.72% |
| 2020 | 2.77 Billion CNY | -0.27% |
| 2019 | 2.78 Billion CNY | 19.84% |
| 2018 | 2.32 Billion CNY | 20.3% |
| 2017 | 1.92 Billion CNY | 6.69% |
| 2016 | 1.8 Billion CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 2.64 Billion CNY | 0.0% |
| 2023 FY | 2.67 Billion CNY | 2.76% |
| 2023 Q2 | 1.04 Billion CNY | 0.0% |
| 2023 Q4 | 1.68 Billion CNY | 0.0% |
| 2022 Q4 | 1.37 Billion CNY | 0.0% |
| 2022 Q2 | 1.22 Billion CNY | 0.0% |
| 2022 FY | 2.6 Billion CNY | -7.56% |
| 2021 FY | 2.82 Billion CNY | 1.72% |
| 2021 Q2 | 1.33 Billion CNY | 0.0% |
| 2021 Q4 | 1.48 Billion CNY | 0.0% |
| 2020 FY | 2.77 Billion CNY | -0.27% |
| 2020 Q4 | 1.43 Billion CNY | 0.0% |
| 2020 Q2 | 1.34 Billion CNY | 0.0% |
| 2019 Q2 | 1.46 Billion CNY | 0.0% |
| 2019 FY | 2.78 Billion CNY | 19.84% |
| 2019 Q4 | 1.31 Billion CNY | 0.0% |
| 2018 FY | 2.32 Billion CNY | 20.3% |
| 2018 Q4 | 1 Billion CNY | 0.0% |
| 2018 Q2 | 1.23 Billion CNY | 0.0% |
| 2017 Q4 | 577.33 Million CNY | 0.0% |
| 2017 Q1 | 483.19 Million CNY | 0.0% |
| 2017 Q2 | 483.19 Million CNY | 0.0% |
| 2017 FY | 1.92 Billion CNY | 6.69% |
| 2016 Q4 | 483.19 Million CNY | 0.0% |
| 2016 Q1 | 451.92 Million CNY | 0.0% |
| 2016 FY | 1.8 Billion CNY | 0.0% |
| 2016 Q2 | 451.92 Million CNY | 0.0% |
| 2015 Q4 | 451.92 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 143.01 Million HKD | -1885.373% |
| Grand Pharmaceutical Group Limited | 2.66 Billion HKD | -6.605% |
| Extrawell Pharmaceutical Holdings Limited | -8.16 Million HKD | 34887.074% |
| Wai Yuen Tong Medicine Holdings Limited | 40.88 Million HKD | -6845.501% |
| Qianhai Health Holdings Limited | -52.18 Million HKD | 5541.084% |
| Lee's Pharmaceutical Holdings Limited | 36.04 Million HKD | -7777.812% |
| Essex Bio-Technology Limited | 310.32 Million HKD | -814.937% |
| Tongfang Kontafarma Holdings Limited | - HKD | -Infinity% |
| PuraPharm Corporation Limited | -66.04 Million HKD | 4399.005% |
| SSY Group Limited | 1.63 Billion HKD | -73.245% |
| JBM (Healthcare) Limited | 174.2 Million HKD | -1529.873% |
| Jacobson Pharma Corporation Limited | 333.12 Million HKD | -752.326% |
| China Resources Pharmaceutical Group Limited | 12.14 Billion HKD | 76.625% |